Needham & Company, LLC's Sixth Annual Biotechnology & Medical Technology Conference New York Palace Hotel June 13-14, 2007
Posted on: Thursday, 7 June 2007, 09:00 CDT
Needham & Company, LLC will hold its Sixth Annual Biotechnology & Medical Technology Conference at the New York Palace Hotel on June 13-14. Over 120 biotechnology and medical technology companies are scheduled to present.
"Investors at our conference are looking for small, undercovered companies that may be developing into the next Amgen," said Dr. Mark Monane, Managing Director, Equity Research, Biotechnology & Life Sciences. "Over the past decade, the large pharmaceutical firms have gone through a significant transition where an important part of their business has come from partnering with and acquiring biotech firms to leverage their drug development and distribution strengths. That leaves much of the discovery of new drugs and exciting breakthroughs to the smaller companies, many of which will be at our conference. We think we host the Tribeca Film Festival of the biotechnology and medical technology community. Once again the conference will come on the heels of the American Society of Clinical Oncology (ASCO) Annual Meeting, so that the information coming out of that event can be analyzed and discussed at our conference."
Topics that attending companies are scheduled to cover include:
Pain: A geriatric medical issue Cancer: Breakthroughs in prostate cancer Obesity: Using natural hormones to reduce the desire to eat Infectious Diseases: New approaches in treating HIV & Hepatitis C epidemics Medical Tech: Hardware to go along with medical options Diagnostics: Tackling osteoporosis and other women's health issues Heart Disease: Avoiding heart attacks
In addition to company presentations, there will be several special panel discussions:
Wednesday, June 13: 10:00 a.m. Medication for pain 10:00 a.m. Obesity 3:00 p.m. Cancer 3:00 p.m. Hepatitis & HIV
Thursday, June 14: 10:00 a.m. Cardiovascular 10:00 a.m. Biotechnology evolution
About Needham & Company, LLC
Needham & Company, LLC, a wholly owned subsidiary of The Needham Group, Inc., is a privately held, full-service investment bank with the mission of helping emerging growth companies achieve their potential. The firm is headquartered in New York City with offices in Boston, Menlo Park and San Francisco. In addition to investment banking, Needham's principal activities include institutional sales and trading and asset management. To serve its institutional clients, Needham & Company, LLC produces comprehensive equity research on more than 350 companies in technology, health care, consumer and industrial growth. Needham & Company, LLC is a member of NASD/SIPC. For more information, please see www.needhamco.com.
Source: Business Wire
Related Articles
- OncoGenex to Present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference
- Targeted Genetics to Present at the Needham & Company Fifth Annual Biotechnology and Medical Technology Conference
- Adeza to Present at Needham & Company's Fifth Annual Biotechnology and Medical Technology Conference; Webcast Scheduled Thursday, June 15 at 3:30 P.M. ET
- Metabasis to Present at Needham & Company Fifth Annual Biotechnology and Medical Technology Conference
- Abiomed to Present at Needham & Company's Fifth Annual Biotechnology and Medical Technology Conference
- Needham & Company's Fifth Annual Biotechnology and Medical Technology Conference in New York on June 14-15; Medical Technology Companies Included for First Time; Record Number of Companies to Present
- Antigenics CEO to Present at Needham & Company Fifth Annual Biotechnology and Medical Technology Conference
- KVH Industries' CEO to Speak at 8th Annual Needham & Company Growth Conference
- KVH Industries' CEO to Speak at 7th Annual Needham & Company Growth Conference
- KVH Industries' CEO to Speak at 6th Annual Needham & Company Growth Conference
User Comments (0)

RSS Feeds